The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123454932 12345493 2 F 20160306 20160809 20160509 20160819 EXP JP-AMGEN-JPNCT2016037677 AMGEN 70.00 YR E F Y 57.00000 KG 20160818 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123454932 12345493 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 340 MG, Q2WEEKS 340 MG Y Y 125147 340 MG SOLUTION FOR INJECTION QOW
123454932 12345493 2 SS panitumumab PANITUMUMAB 1 Intravenous drip 340 MG, Q2WEEKS 340 MG Y Y 125147 340 MG SOLUTION FOR INJECTION QOW
123454932 12345493 3 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 580 MG, Q2WEEKS 4070 MG U 0 580 MG QOW
123454932 12345493 4 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 3490 MG, Q2WEEKS 4070 MG U 0 3490 MG QOW
123454932 12345493 5 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 200 MG/M2, Q2WK 4070 MG U 0 200 MG/M**2 QOW
123454932 12345493 6 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 2000 MG/M2, Q2WK 4070 MG U 0 2000 MG/M**2 QOW
123454932 12345493 7 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 120 MG, Q2WEEKS 120 MG U 0 120 MG QOW
123454932 12345493 8 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 65 MG/M2, Q2WEEKS 120 MG U 0 65 MG/M**2 QOW
123454932 12345493 9 SS ISOVORIN /06682103/ LEUCOVORIN CALCIUM 1 Intravenous drip 290 MG, Q2WEEKS 290 MG U 0 290 MG QOW
123454932 12345493 10 SS ISOVORIN /06682103/ LEUCOVORIN CALCIUM 1 Intravenous drip 290 MG, Q2WEEKS 290 MG U 0 290 MG QOW
123454932 12345493 11 SS ALOXI PALONOSETRON HYDROCHLORIDE 1 Intravenous drip 0.75 MG, UNK U 0 .75 MG
123454932 12345493 12 SS PROEMEND FOSAPREPITANT 1 Intravenous drip 150 MG, UNK U 0 150 MG
123454932 12345493 13 SS DEXART DEXAMETHASONE SODIUM PHOSPHATE 1 Intravenous drip 6.6 MG, UNK U 0 6.6 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123454932 12345493 1 Colon cancer
123454932 12345493 3 Colon cancer
123454932 12345493 7 Colon cancer
123454932 12345493 9 Colon cancer
123454932 12345493 11 Prophylaxis of nausea and vomiting
123454932 12345493 12 Prophylaxis of nausea and vomiting
123454932 12345493 13 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
123454932 12345493 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123454932 12345493 Condition aggravated Condition aggravated
123454932 12345493 Deep vein thrombosis
123454932 12345493 Nausea
123454932 12345493 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123454932 12345493 1 20160302 20160302 0
123454932 12345493 2 20160331 0
123454932 12345493 3 20160302 20160302 0
123454932 12345493 4 20160302 20160304 0
123454932 12345493 5 20160331 0
123454932 12345493 6 20160331 0
123454932 12345493 7 20160302 20160302 0
123454932 12345493 8 20160331 0
123454932 12345493 9 20160302 20160302 0
123454932 12345493 10 20160331 0
123454932 12345493 11 20160302 20160302 0
123454932 12345493 12 20160302 20160302 0
123454932 12345493 13 20160302 20160302 0